To determine the association between dietary calcium intake and bone mineral density (BMD) in individuals with HIV, HCV, or both, and to assess the prevalence of osteopenia and osteoporosis in these groups.
Key Findings:
Osteoporosis and osteopenia were prevalent among participants, but no significant association was found between infection group and BMD results.
HCV-infected patients with osteoporosis had lower calcium intake compared to those with normal BMD.
Dietary calcium intake correlated with reduced BMD only in patients with HCV monoinfection.
Interpretation:
The study suggests that while dietary calcium intake is important for bone health, its direct impact on BMD may vary depending on the type of viral infection, particularly highlighting the need for targeted nutritional interventions in HCV-infected individuals to improve bone health outcomes.
Limitations:
Cross-sectional design limits causal inferences.
Sample size may not be representative of the broader population.
Calcium intake assessment relies on self-reported data, which may introduce bias.
The study's setting may limit the generalizability of the findings.
Conclusion:
The findings indicate a specific relationship between dietary calcium intake and BMD in HCV-infected individuals, underscoring the importance of monitoring calcium consumption in this population to prevent bone health deterioration.
